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Loss of CD28 is a characteristic feature of T cell aging, but the underlying mechanisms 
of this loss are elusive. As differential expression of microRNAs (miRNAs) has been 
described between CD28+ and CD28− T cells, we hypothesized that altered miRNA 
expression contributes to the age-associated downregulation of CD28. To avoid 
the confounding effects of age-associated changes in the proportions of T cells at 
various differentiation stages in  vivo, an experimental model system was used to 
study changes over time in the expression of miRNA associated with the loss of 
CD28 expression in monoclonal T  cell populations at a lower or higher number of 
population doublings (PDs). This approach allows identification of age-associated 
miRNA expression changes in a longitudinal model. Results were validated in 
ex vivo samples. The cumulative number of PDs but not the age of the donor of the 
T cell clone was correlated with decreased expression of CD28. Principal component 
analysis of 252 expressed miRNAs showed clustering based on low and high PDs, 
irrespective of the age of the clone donor. Increased expression of miR-9-5p and 
miR-34a-5p was seen in clones at higher PDs, and miR-9-5p expression inversely 
correlated with CD28 expression in ex vivo sorted T-cells from healthy subjects. We 
then examined the involvement of miR-9-5p, miR-34a-5p, and the members of the 
miR-23a~24-2 cluster, in which all are predicted to bind to the 3′UTR of CD28, in 
the IL-15-induced loss of CD28 in T cells. Culture of fresh naive CD28+ T cells in the 
presence of IL-15 resulted in a gradual loss of CD28 expression, while the expression 
of miR-9-5p, miR-34a-5p, and members of the miR-23a~24-2 cluster increased. 
Binding of miR-9-5p, miR-34a-5p, miR-24-3p, and miR-27- 3p to the 3′UTR of CD28 
was studied using luciferase reporter constructs. Functional binding to the 3′UTR was 
shown for miR-24-3p and miR-27a-3p. Our results indicate involvement of defined 
miRNAs in T cells in relation to specific characteristics of T cell aging, i.e., PD and 
CD28 expression.
Keywords: T cell aging, senescence, cD28, il-15, mirna, mir-9, mir-23a~24-2
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inTrODUcTiOn
Full activation of naive T cells requires binding of the T cell recep-
tor (TCR) to antigens displayed by the major histocompatibility 
complex on antigen-presenting cells (APCs) (known as “signal 
one”) together with ligation of a T  cell costimulatory receptor 
(“signal two”). The latter is archetypically mediated by CD28 on 
the T cell surface and CD80 or CD86 on the APC. This interac-
tion results in complex signaling cascades which activate T cells, 
promote their differentiation, proliferation, and effector function, 
and mounts adaptive immune responses depending on clonally 
expanded, antigen-specific effector T  cells and the subsequent 
generation of T cell memory (1). Costimulation via CD28 low-
ers the threshold for signaling via the TcR and triggers cytokine 
production. This allows T cells to respond to low abundance and 
low avidity antigens, and shapes T cell immunity by balancing the 
interplay between effector and regulatory T cells (1). The latter is 
especially important in focusing the immune response toward the 
pathogen, avoiding autoimmunity, and for downregulating the 
immune response upon pathogen clearance.
The composition and function of the T cell immune system 
in older people is characterized by lower proportions of naive 
T  cells and higher proportions of memory T  cells as a result 
of antigen exposure over the lifetime (2). Additionally, aging 
itself affects the characteristics of T  cells within the naive and 
memory compartments and when these effects result in com-
promised functionality, these T cells can be designated “immu-
nosenescent” (2–4). Developmentally programmed thymic 
involution at puberty results in an abrupt decline in the output 
of naive T  cells, although residual thymic activity maintains 
the production of small numbers of such cells in most people 
in their 50s or 60’s. The diversity of the memory T  cell pool 
increasingly reflects pathogen exposures over the lifetime, 
especially its focus on maintaining immune surveillance of 
latent viruses, e.g., CMV, EBV, and many other pathogens (5, 6). 
Overall, numbers and proportions of naive T  cells decline, 
despite partial compensation by homeostatic proliferation of 
these cells in the periphery, which may also contribute to their 
aging phenotype (7, 8). Repeated clonal expansions of memory 
cells on rechallenge by specific pathogens, or continuous chal-
lenges by persistent pathogens, are thought to be instrumental 
for the overall differences observed between T cells in younger 
and older individuals (9, 10). At the cellular level, T cell aging 
is characterized by a multitude of changes in the expression 
of cell surface proteins. Most notably, a gradual decline in the 
expression of CD28 has been reported as a characteristic feature 
of aged T cells, mostly but not only due to the age-associated 
accumulation of late-stage memory cells which do not express 
this coreceptor (11, 12). The exact mechanisms involved in the 
aging-related decline of CD28 are unknown. Dissecting the 
differences in CD28 expression resulting from altered propor-
tions of naive and memory T cells with age, and the intrinsic 
aging process within single T  cell populations is challenging. 
To approach this, we have employed monoclonal T cells with 
increasing population doublings (PDs) in culture as a longitu-
dinal aging model to identify regulation of CD28 expression, 
and attempted to validate some of these in ex vivo sorted T-cells 
from healthy subjects (13, 14) Here, we report the activity of 
microRNAs (miRNAs) in this context.
MicroRNAs are small noncoding RNA molecules that regulate 
protein expression by interfering with the process of messenger 
RNA (mRNA) translation or by inducing mRNA degradation. 
miRNAs are crucially involved in T cell development, differen-
tiation, activation, and function (15, 16). In addition, recent 
evidence has implicated the involvement of miRNAs in several 
aspects of T  cell aging (15–19). However, if and how miRNAs 
are involved in the regulated decline of CD28 expression is 
unknown. High expression of the three members of the miR-
23a~24-2 cluster in CD8+CD28− T cells relative to CD8+CD28+ 
T cells has been reported (20). Increased expression of miR-24 
in CD28− T cells was associated with an increased susceptibility 
to cell death, which was counterbalanced by IL-15 (20). IL-15 
is a homeostatic cytokine that supports survival and prolifera-
tion of naive CD28+ T cells in the absence of continuous TCR 
stimulation (21). Downregulation of CD28 in response to home-
ostatic cytokines, such as IL-15, which interact with common 
γ-chain receptors, has been well documented (21–23). Here, 
we studied the involvement of miRNAs in clonal expansion 
and IL-15-regulated expression of CD28 by T cells. Using T cell 
clones derived from healthy young and elderly donors, we 
observed clustering of miRNAs primarily according to the num-
ber of PDs. In addition, IL-15 induced loss of CD28 coincided 
with upregulation of miRNAs that interact with the 3′UTR of 
CD28 mRNA.
MaTerials anD MeThODs
generation of T cell clones
T  cell clones were generated from phytohemagglutinin- 
stimulated peripheral blood mononuclear cells (PBMC) by 
limiting dilution in the presence of IL-2 and pooled irradiated 
PBMC feeder cells as described previously (13, 24–26). In brief, 
cells to be cloned were plated at 0.45/well into 1 mm-diameter 
microplate wells containing 104 30 Gy-irradiated pooled PBMC 
from >20 random normal donors as feeder cells. Contents of 
positive wells were transferred after 1–2 weeks to 96-well 7 mm-
diameter flat bottomed microtiter plate containing fresh medium 
and 105 pooled PBMC feeder cells between day 7 and 11, and to 
16 mm-diameter 24-well cluster plate with 2.5 × 105 stimulators 
between day 12 and 16. Cultures were given fresh medium every 
3 or 4  days and fresh feeder cells every 1–2  weeks thereafter. 
Clonal age is expressed in PD estimated by microscopic count-
ing of the cells at each subculture and counting the number of 
doublings cumulatively undergone. Culture medium was the 
serum-free formulation X-Vivo 10 (BioWhittaker, Walkersville, 
MD, USA).
Three T  cell clones from two healthy old and three T  cell 
clones from one healthy young donor each at low and high PDs 
were selected for small RNA sequencing (n = 12 samples; three 
independent samples for each condition tested). Additional 
clones were used for the quantitative reverse-transcription-
polymerase chain reaction (qRT-PCR) validation experiments 
(Table S1 in Supplementary Material). T-cell clones used were 
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all CD4+. CD28 expression on T cell clones with low and high 
numbers of PDs was assessed by standard quantitative flow 
cytometry and expressed as median fluorescence intensity as 
reported previously (24, 25).
Primary lymphocyte subsets
Peripheral blood mononuclear cells were freshly isolated by 
density gradient centrifugation using Lymphoprep (Axis-Shield, 
Oslo, Norway) according to the manufacturer’s protocol. Infor-
med consent was obtained from all participants in accordance 
with the Declaration of Helsinki. The Medical Ethical Committee 
of the University Medical Center Groningen approved the study. 
For validation of differential miR-9-5p and miR-34a-5p expres-
sion in CD28+ versus CD28− T cells, CD3+CD28+ and CD3+ 
CD28− cells were fluorescence-activated cell sorting (FACS) 
sorted from six healthy young (<30 years) and four healthy old 
(>60 years) subjects. For IL-15 culture experiments, CD3+CD8
+CD45RO−CCR7+CD28+ T cells were FACS sorted from six 
healthy young (<30 years) subjects.
Facs of human Primary lymphocyte 
subsets and analysis of cell  
surface Markers
The following monoclonal antibodies were used: anti-CD3-e450 
(OKT3), anti-CD8a-APC-e780 (OKT8) (eBioscience, Vienna, 
Austria), anti-CD45RO-FITC (UCHL1), anti-CCR7-PE (3D12) 
(BD Bioscience, Breda, Netherlands), and anti-CD28 PeCy7 
(CD28.2) (Biolegend, Uithoorn, The Netherlands). Cells were 
sorted using a MoFlo flow cytometry cell sorter (Backman 
Coulter, Woerden, The Netherlands).
Expression of cell surface markers on T  cells was assessed 
using mAbs against human CD28-PE-CY7 (CD28.2) (Biolegend), 
CCR7-PE (3D12), and CD45RO-FITC (UCHL1) (BD Biosciences). 
Cells were analyzed using a BD LSR-II Flow Cytometer and the 
Diva software (BD Biosciences). Data analysis was done using the 
Kaluza Flow Analysis Software (1.2) (Beckman Coulter).
T cell culture With human  
recombinant il-15
Fluorescence-activated cell sorting-sorted CD3+CD8+CD28+ 
CD45RO−CCR7+ (naive CD8+) T  cells were suspended in 
RPMI medium (Lonza, Breda, The Netherlands) supplemented 
with 10  mg/ml gentamycin sulfate (Lonza) and 10% fetal calf 
serum (Thermo Scientific, Breda, The Netherlands) in a volume 
of 3 ml and seeded at a density of 1 × 106/ml in T25 cm flasks. 
A final concentration of 50  ng/ml human recombinant IL-15 
(Peprotech, London, UK) was added to the cell culture at day 
0 and refreshed every 5th day. On day 5, 10, and 15 of culture, 
cells were harvested and stained for flow cytometry analysis and/
or lysed for RNA isolation. To study CD28, CD45RO, and CCR7 
expression on naïve CD8+ T cells after IL-15 stimulation, CD3+
CD8+CD28+CD45RO−CCR7+ T-cells were sorted as described 
above and stained with 10  umol/ml eF670 proliferation dye 
(eBioscience, Vienna, Austria). After 5, 10, and 15 days of culture 
in the presence of IL-15 (50 ng/ml), cells were harvested, stained, 
and analyzed by flow cytometer.
culture of cOs-7 cells
COS-7 cells (African Green Monkey SV40-transformed kidney 
fibroblast cell line) were cultured in Dulbecco modified Eagle 
medium supplemented with 10% fetal bovine serum (Thermo 
Fisher Scientific, Breda, The Netherlands), 200 mM l-glutamine 
and 10 mg/ml gentamycin sulfate (Lonza, Breda, The Netherlands) 
at 37°C in 5% CO2.
rna isolation
Total RNA was extracted using the miRNeasy Mini Kit (Qiagen, 
Venlo, The Netherlands) following the manufacturer’s instruc-
tions. Micro Bio-SpinTM chromatography columns, supplied 
with Bio-Gel P-6 polyacrylamide gel matrices, were applied to 
maximize purity of the RNA samples (Bio-Rad laboratories). 
The ExperionTM RNA stdSens and HighSens analysis kits (Life 
Science, Bio-Rad Laboratories B.V, Veenendal, The Netherlands) 
were used to determine the RNA quality indicator score. The RNA 
concentration was measured on a NanoDrop ND-1000 Spectro-
photometer (NanoDrop Technologies, Wilmington, DE, USA).
small rna sequencing and Data analysis
T cell clones with the biggest difference between low and high 
PDs were selected for small RNA-sequencing. Samples were 
barcoded and sequenced with Illumina HiSEQ 2000 flowcell 
(Illumina). The sequence reads were analyzed using the CLC BIO 
Genomic Work Bench Suite 4.5 (CLC BIO, Arhus, Denmark). 
Reads were mapped to the mature miRNAs using miRDeep2 
(27). The number of mapped reads of each sample was normal-
ized to 1 × 106. Normalized data were imported to GeneSpring 
(v.11.5.1) for analysis. A total of 252 miRNAs were present in at 
least 3 out of 12 samples with a read count >10. Mann–Whitney U  
test was performed to identify significantly differentially expressed 
miRNAs. Genesis (Release 1.7.6) was used to generate heatmaps. 
Raw and processed data are available via the Gene Expresison 
Omninbus, accession #GSE106619.
Quantitative rT-Pcr
MicroRNA and gene expression levels were determined by 
qRT-PCR. cDNA synthesis for miRNAs was performed with 
Taqman miRNA Reverse Transcription kit using a multiplex 
reverse transcription approach with TaqMan microRNA Assays 
(Life Technologies, Carlsbad, CA, USA): for miR-9-5p (000583), 
miR-23a-3p (000399), miR-24-3p (000402), miR-27a-3p (000408), 
miR-31-5p (002279), miR-34a-5p (000426), and RNU44 (001094). 
RNU44 served as an endogenous control.
The qPCR reaction was performed using qPCR MasterMix 
Plus (Eurogentec, Liege, Belgium) and mean cycle threshold 
(Ct) values for all genes were quantified with the ViiA™ 7 soft-
ware (Life Technologies). Relative expression levels were quanti-
fied using the 2−ΔCt (ΔCt = Ct gene − Ct reference gene) method.
cloning of 3′UTr in a luciferase reporter 
construct, Transient Transfection,  
and luciferase reporter assays
The CD28 3′UTR was cloned into the psiCHECK2 vector 
(Promega, Madison, WI, USA) in two fragments, as previously 
FigUre 1 | The population doublings (PDs) of T cell clones inversely 
correlate with CD28 expression. CD4+ T cell clones used for small RNA 
sequencing (filled symbols) with high and low PD and additional T cell  
clones (open symbols) were fluorescence-activated cell sorting analyzed for 
expression of CD28. Shown is the relation between CD28 expression based 
on mean fluorescence intensity (MFI) and PD of the T-cell clones. For one of 
the clones no MFI data are available.
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described (28). CD28 3′UTR-1 (nt 870-2279 of ENST00000324106.8) 
was amplified from genomic DNA using primers containing an 
Xhol (5') or Notl (3') restriction site, forward: 5′-GCTCCTGC 
ACAGTGACTACA-3′, reverse 5′-ACCTTCTGCCTGACCACT 
TC-3′. CD28 3′UTR-1mut (same as above but with mutated 
miRNA binding sites), CD28 3′UTR-2 (nt 2534-4449), and CD28 
3′UTR-2mut were ordered as minigenes (IDT, Leuven, Belgium). 
For both CD28 UTR-mut constructs mutations at position 2, 
4, and 6 of the seed sequences were introduced at all potential 
miR-9-5p, -24-3p, -27-3p, and -34a-5p binding sites (based on 
sites indicated in Figure  5A). Sequences for the constructs 
are available on request. The inserts were sequence verified 
(BaseClear, Leiden, The Netherlands). COS-7 cells were trans-
fected with 125 ng of the psiCHECK2 construct and either 50 nM 
hsa-miR-9-5p (PM10022), hsa-miR-24-3p (MC10737), hsa- 
miR-27a-3p (MC10939), hsa-miR-34a-5p (MC11030) mimics, or 
miRNA precursor negative control #1 (AM17110, ThermoFisher) 
using Saint-MIX (Synvolux products, Leiden, The Netherlands) 
following manufacturer’s instructions. Cells were lysed 48 h after 
transfection and Renilla and Firefly luciferase activity was assessed 
using Dual-Luciferase Reporter Assay System (Promega) accor-
ding to manufacturer’s protocol. For each transfection, luciferase 
activity was measured in duplicate with the Luminoskan Ascent 
Microplate Luminometer (Thermo Scientific). The Renilla over 
Firefly (RL/FF) luciferase ratios were calculated and the RL/FF 
ratio of control precursor was set to one. All luciferase measure-
ments were performed in at least three independent experiments.
statistical analysis
For correlation analysis between miRNA or CD28 expression 
and PD the Spearman test was used. Paired samples as presented 
in Figures  2E,F were analyzed using the Wilcoxon signed-
rank test and for Figures  3 and 4B,D (Figures S3B–D,H–J in 
Supplementary Material) and Figure 5 using the Friedman test 
with post hoc Dunnett’s multiple comparison test. Results obtai-
ned from luciferase assay were analyzed using the paired T-test. 
Statistical analyses were performed with GraphPad Prism version 
7.0 (GraphPad Software, San Diego, CA, USA).
resUlTs
PDs of T cells associates With Differential 
expression of cD28 and mirnas
For all 16 T  cell clones, a passage at a lower number of PDs 
(≤40, median 29) and a passage at a high number of PDs (>40, 
median 56) was used (Table S1 in Supplementary Material). The 
Mean fluorescence intensity (MFI) of CD28 showed an inverse 
correlation with the number of PDs (Figure  1), which is in 
line with previous work (Figure  1) (14). No changes in CD28 
expression were observed in the different age groups in which 
clones were grouped (data not shown). Small RNA sequencing 
was performed on the highest and lowest PD passage of 6 T cell 
clones. The T-cell clones used for this analysis were selected based 
on PD passages at the lowest and highest end of the PD spectrum.
Principal component analysis of the 252 miRNAs detected 
in at least 3 of 12 samples revealed a perfect separation of the 
T cell clones in the first component based on PD (Figure 2A). 
No clustering was observed according to the age of the donor. 
Ten miRNAs were significantly differentially expressed between 
T cell clones with a low and a high number of PDs (Figure 2B). 
Five of these ten miRNAs were selected for validation based on 
having high expression levels and a more than 1.5-fold change 
in expression levels (see Table S2 in Supplementary Material). 
Validation was done by qRT-PCR on the 6 T cell clones that had 
been included for small RNA sequencing complemented with 10 
additional T cell clones, also harvested at (intermediate) low and 
a high PD, giving a total of 32 samples (Table S1 in Supplementary 
Material). We observed a significant correlation for both miR-9-5p 
and miR-34a-5p levels with the number of PDs of the T  cell 
clones (Figures 2C,D) and not for the other three miRNAs (data 
not shown).
independent Validation in Primary  
T cell subsets
To further validate the association between miR-9-5p and 
miR-34a-5p with aged T cells and CD28 loss, we sorted CD3+ 
CD28+ and CD3+CD28− T cells from peripheral blood of six 
healthy young (<30  years) and four healthy old (>60  years) 
subjects. In line with the results obtained from the high and low 
PD T cell clones, qRT-PCR analysis revealed significantly higher 
levels of miR-9-5p in the CD3+CD28− T  cell population as 
compared to the CD3+CD28+ T cells (Figure 2E). No significant 
differences were observed for miR-34a-5p (Figure 2F). Of note, 
lower relative expression levels of both miR-9-5p and miR-34a-5p 
were observed in the primary sorted T-cells, compared to the 
T-cell clones.
Upregulation of mirnas by il-15  
in naïve cD8+ T cells
Regulation of CD28 expression in CD8+ T  cells has been 
described to occur downstream of IL-15. This prompted us to 
investigate whether IL-15 regulated the expression levels of miR-
9-5p and miR-34a-5p. We also included miR-23a-3p, miR-24-3p, 
FigUre 2 | MicroRNAs (miRNA) expression analysis in CD4+ T cell clones reveals primarily clusters according to the proliferative history of the T cell clones and 
partly correlates with the expression of CD28. (a) Principal component analysis identifies low population doublings (PDs) (purple samples) versus high PDs (green 
samples) as the primary identifier of biological variation for miRNA expression. Triangles indicate young and squares old donors and numbers correspond to the 
T cell clone numbers indicated in Table S1 in Supplementary Material. (B) Hierarchical clustering of the T cell clones according to low and high PDs based on the 10 
most significantly differentially expressed miRNAs. Correlation between (c) miR-9-5p and (D) miR-34a-5p and the PDs of the T cell clones used in the analysis. 
Filled symbols denote T cell clones used in the small RNA-sequencing samples and open symbols denote additional T cell clones used to validate data from small 
RNA-sequencing. Significant higher expression of (e) miR-9-5p but not (F) miR-34-5p in fluorescence-activated cell sorting-sorted CD3+CD28− T cells versus 
CD3+CD28+ T cells. Expression levels of the miRNAs relative to the expression of RNU44 is shown. Significance (**P ≤ 0.01) is depicted.
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and miR-27a-3p all belonging to the miR-23a~24-2 cluster, 
in this analysis as differentially expression in CD28+ versus 
CD28− T cells has been previously described (20).
To this end, we first sorted naive CD8+CD28+ T  cells and 
cultured them for 15  days in the presence of IL-15 (Figure S1 
in Supplementary Material). Culturing naive CD8+CD28+ 
T cells in the presence of IL-15 resulted in a shift to a memory 
phenotype as shown by a gain of CD45RO expression and a 
concomitant decrease in the expression of CCR7 (Figures 3A,B) 
and CD3 (data not shown). In line with the literature (21–23), 
we observed a significant downregulation of CD28 expression 
by naive T cells in response to IL-15. The percentage of CD28+ 
T  cells decreased to 36% after 15  days culture in the presence 
of IL-15 (Figure 3C). Next to the decrease in the percentage of 
CD28+ T cells, also the expression of CD28 per cell was measured 
by the MFI decreased significantly (Figure 3D).
association Between mirna Binding to 
the 3′UTr of cD28 and cD28 expression
Next we studied whether IL-15-induced downregulation of CD28 
was directly related to cell division. Analysis of sorted naïve 
T-cells stained with a proliferation dye revealed a progressive 
downregulation of CD28, both in terms of percentage positive 
cells and expression level, directly related to the number of cell 
divisions. Cells that did not divide retained CD28 expression. 
Similarly, cell division also correlated with acquiring a memory 
phenotype, as denoted by a loss of CCR7 and gain of CD45RO 
FigUre 3 | IL-15 induces loss of CD28 by naive CD8+ T cells. Fluorescence-activated cell sorting-sorted naive CD8+CD45RO−CCR7+CD28+ T cells were 
cultured in the presence of IL-15 (50 ng/ml). Directly after sorting and after 5, 10, and 15 days of culture, expression of (a) CD45RO, (B) CCR7, and (c,D) CD28 
was assessed. MFI = median fluorescence intensity. Significance (*p < 0.05, **p < 0.01, ***p < 0.001) is depicted. N = 6.
6
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expression. These differences were most pronounced at day 15, 
but were also seen after 5 and 10  days stimulation with IL-15 
(Figures S2 and S3 in Supplementary Material).
Expression levels of the five selected miRNAs were assessed 
directly after sorting cells and after 5, 10, and 15 days of culture in 
the presence of IL-15. Expression of miR-9-5p, miR-34a-5p, miR-
23a-3p, miR-24-3p, and miR-27a-3p increased over the 15  days 
of culture with similar kinetics for miR-34a-3p (Figure 4B) and 
the members of the miR-23a~24-2 family (Figures 4C–E). MiR-
9-5p levels increased already at day 5, although to a lower extend 
(Figure  4A). Absolute expression levels significantly differed 
between the miRNAs with miR-24-3p having the highest and 
miR-9-5p the lowest expression levels. As a control, we tested the 
expression of a randomly selected unrelated miRNA (miR-31-5p), 
which did not significantly change as a result of stimulation with 
IL-15 (Figure 4F).
Next, we identified putative miRNA binding sites in the 
3′UTR of the CD28 mRNA. Using the Targetscan miRNA 
binding site prediction algorithm as well as manual searches for 
6-, 7-, and 8-mer seed binding sites we identified two binding sites 
for miR-9-5p, miR-23a-3p, and miR-34a-5p and three binding 
sites for miR-24-3p and miR-27a-3p (Figure 5A). The presence of 
binding sites for these IL-15 responsive miRNAs in the 3′UTR of 
the CD28 transcript suggests a direct regulation. Two consecutive 
regions covering the 3′UTR of CD28 were cloned in a luciferase 
reporter construct for analysis to assess direct binding of miR-
9-5p, miR-34a-5p, and the two most abundant members of the 
miR-23a~24-2 family (miR-24-3p and miR-27a-3p). In addition, 
we also generated CD28 3′UTR constructs in which the binding 
sites of the four miRNAs were mutated. COS-7 cells were tran-
siently transfected with these constructs and specific miRNAs 
or control mimics. Luciferase assays using the wild-type (WT) 
CD28 3′UTR regions indicated binding of miR-9-5p, miR-24-3p, 
and miR-27a-3p to CD28-UTR-1 and of miR-24-3p to CD28-
UTR-2 (Figures 5A,B). Comparison of WT to mutated constructs 
indicated that the relative R/F ratio of miR-27a-3p alone and in 
combination with miR-24-3p was reduced, albeit not significant 
(p-value = 0.11, p-value = 0.058, Figure 5C). For CD28-UTR-2 a 
reduced relative R/F ratio was observed for miR-24-3p and miR-
34a-5p (p-value = 0.0062, p-value = 0.012, Figure 5C). Together 
these data suggest that miR-24-3p and miR-27a-3p are the most 
important miRNAs for direct regulation of CD28 expression.
DiscUssiOn
Loss of CD28 is regarded as a hallmark of T cell aging (11, 14). 
To study T cell aging, various in vitro models have been applied, 
among which are T  cell clones and IL-15 treatment of naive 
CD28+ T  cells (21–24). We showed an inverse correlation 
between both miR-9-5p levels and miR-34a-5p, and CD28 expr-
ession in T cell clones with low and high PDs, in aged primary 
T cells and in IL-15 exposed naive T cells. In the latter model, 
we also showed IL-15 induced upregulation of the members of 
the miR-23a~24-2 cluster. Luciferase reporter assays showed 
FigUre 4 | Expression of miR-9-5p, miR-34a-5p, and miR-23a~24-2 cluster in CD8+ naive T cells is regulated by IL-15. Fluorescence-activated cell sorting-sorted 
naive CD8+CD45RO−CCR7+CD28+ T cells were cultured in the presence of IL-15 (50 ng/ml). Directly after sorting and after 5, 10, and 15 days of culture, 
expression levels of (a) miR-9-5p, (B) miR-34a-5p, (c) miR-23a-3p, (D) miR-24-3p, (e) miR-27a-3p (all three part of the miR-23a~24-2 cluster), and (F) as a 
non-IL-15-responsive control, miR-31-5p were assessed by RT-qPCR. Expression levels of the microRNAs (miRNAs) relative to the expression of RNU44 are shown. 
Significance (*p < 0.05, **p < 0.01, ***p < 0.001) is depicted. N = 6.
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targeting of the 3′UTR of the CD28 transcript by miR-24 and 
miR-27a, indicating miRNA dependent regulation of CD28 exp-
ression upon T cell aging.
The negative correlation between the number of PDs and the 
expression level of CD28 in T cell clones is consistent with their 
previously reported senescent phenotype (13, 14). We showed 
a clear PD-associated difference in miRNA expression levels 
in T cell clones, which was independent of the age of the T cell 
donor. These observations are consistent with previous findings 
showing an overall immune-biological similarity between T cell 
clones from centenarian and young adults (26, 29) and confirm 
that centenarian-derived T cell clones are, per se, not function-
ally compromised. We identified 10 miRNAs with a significant 
differential expression pattern in T cell clones with low and high 
number of PDs and confirmed an association with the number of 
PDs for miR-9-5p and miR-34a-5p. For miR-9-5p, we validated 
higher miR-9-5p levels in primary CD28− T cells as compared to 
CD28+ T cells isolated from both young and old subjects.
In a second model system used in this study, we assessed the 
kinetics of miR-9-5p and miR-34a expression in naive CD28+ 
T  cells in response to IL-15. IL-15 expression increases with 
age and maintains survival of effector CD8+ T-cells. Increased 
expression of IL-15 in aged individuals has been implicated in the 
loss of CD28 expression by T-cells (6). In line with literature find-
ings, culture of naïve CD8+ T cells with IL-15 induced a memory 
phenotype and concomitant gradual downregulation of CD28 
in the proliferating cell fraction. We show that IL-15 mediated 
downregulation of CD28 by naïve CD8+CD28+ T cells is associ-
ated with a concomitant upregulation of miR-9-5p, miR-34a-5p, 
and the three members of the miR-23a~24-2 cluster. This con-
firms the previously reported high expression of the members of 
the miR-23a~24-2 cluster in CD28− T cells compared to CD28+ 
T cells (20). It remains to be established whether IL-15 induced 
miRNA expression involves other cytokines besides IL-15, such 
as TNF-a, which has also been implicated in the regulation of 
CD28 expression (30, 31).
Aging-related changes in expression of cell surface receptors 
are not restricted to CD28. Specifically, CD3γ regulated modula-
tion of the TcR/CD3 complex has been reported in relation to 
aging (32). Downregulation of CD28 expression in our study was 
not seen as a result of stimulation by common γ-chain interacting 
cytokines per se, as culturing T cells in the presence of IL-4 did 
not induce downregulation of CD28 expression (data not shown). 
However, implication of the epigenome in the aging immune 
signature of memory CD8 T cells, involving silencing of the IL-7R 
gene and IL-7 signaling, has been described previously (33, 34).
As a mechanism to explain IL-15 induced loss of CD28 expres-
sion, we propose involvement of miRNAs targeting of the 3′UTR 
of the CD28 transcript. Indeed, several potential binding sites 
of miR-9-5p, miR-34a-5p, and miR-23a~24-2 cluster members 
are present in the 3′UTR of CD28. Using a luciferase reporter 
assay we confirmed binding of miR-24-3p and miR-27a-3p to the 
3′UTR of the CD28 transcript, thus providing evidence for their 
functional involvement in the regulation of CD28 expression 
upon induction by IL-15.
We initiated our search for aging associated miRNAs with CD4+ 
T-cell clones. This allowed us to analyze both high and low PD 
samples of the same T cell clone. Because CD28 expression is regu-
lated more profoundly in CD8+ T cells and previous studies have 
been conducted specifically using CD8+ T cells, we subsequently 
used sorted naïve CD8+ T cells to study IL-15 stimulation induced 
regulation of miRNAs and CD28 expression. We confirmed dif-
ferential expression for miR-9-5p and miR-34a-5p. Between the 
various experimental settings, we noted considerable differences 
FigUre 5 | MicroRNAs (miRNAs) binding site analysis of the CD28 3′UTR. 
(a) Schematic overview of the predicted miRNA binding sites for miR-9-5p, 
miR-34a-5p, and members of the miR-23a~miR-24-2 cluster in the 3′UTR 
of CD28 (ENST00000324106.8). Binding sites were identified using the 
Targetscan prediction algorithm (release 7.1) in combination with a manual 
search for 6mers. The arrow indicates the two regions that were cloned in 
the luciferase reporter constructs. 8mer: exact match to positions 2–8 of the 
mature miRNA followed by an A, 7mer-m8: exact match to positions 2–8 of 
the mature miRNA, 7mer-A1: exact match to positions 2–7 of the mature 
miRNA followed by an A and 6mer: exact match to positions 2–7 of the 
mature miRNA. (B) Binding analysis of miR-9-5p, miR-24-3p, and 
miR-27a-3p to the proximal part of the CD28 3′UTR (CD28-UTR-1, left) and 
of miR-9-5p, miR-24-3p, and miR-34a-5p to the distal part (CD28-UTR-2 
right). Cos-7 cells were transfected with psi-Check-2 construct harboring 
each fragment of the 3′UTR of CD28 (a) in combination with control 
precursor, or the miRNA(s) as indicated. The Renilla (R) over Firefly (F) 
luciferase ratio set to one for the control precursor transfected cells is 
shown. (c) The normalized R/F ratio of the wild-type CD28 UTR region 
relative (rel) to the normalized R/F ratio of the same region with mutated 
binding sites for the tested miRNAs. Significance (*p < 0.05, **p < 0.01, 
***p < 0.001) is depicted. Each luciferase experiment was measured in 
duplicate and each experiment was performed at a minimum of three 
independent experiments.
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in the expression level of the miRNAs studied. Expression of miR-
NAs is cell type dependent and might, as such, explain differences 
observed between the various experimental settings.
We used a luciferase reporter system to verify functional 
binding of miR-9-5p miR-24-3p, miR-27a-3p and miR-34a-5p 
to the 3ʹUTR of CD28. Two approaches were followed, the first 
using WT 3′UTR constructs in combination with miRNA pre-
cursor overexpression and the second using 3′UTR constructs 
in which seed sequences of the miRNAs had been mutated. The 
combined analysis indicated that miR-24-3p and miR-27a-3p 
was the most effective in binding to the 3′UTR of CD28. It 
should be noted that results were obtained using COS-7 cells 
and it remains to be determined whether these results can be 
translated to T-cells. However, transducing T-cells directly 
with these constructs is not only technically complicated but 
also induces unpredictable activation-associated physiological 
changes.
The aging-related decline in CD28 expression is observed in 
human T cells but not in rodents. Notably, two of three miR-27a 
binding sites are missing in the 3′UTR of mouse CD28. On the 
other hand, the 3′UTR of mouse CD28 has one additional miR-
24 binding site compared to the 3ʹUTR of human CD28. Such 
differences, but also other differences including higher or lower 
miRNA or target gene levels can explain differences in miRNA-
mediated CD28 regulation between humans and rodents.
In conclusion, our results provide evidence for involvement 
of miRNAs in the process of replication-associated aging and 
IL-15-mediated regulation of CD28 expression. The data sup-
port a positive feedback loop in which IL-15 induces loss of 
CD28 and induction of miR-9 as well as the members of the 
miR-23a~24-2 cluster during T cell aging. The induced loss of 
CD28 and associated senescent phenotype of aged T cells may 
be stabilized or further enhanced by induction of the IL-15-
induced miRNAs.
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FigUre s1 | Sorting strategy of CD8+CD45RO−CCR7+CD28+T cells.
FigUre s2 | Loss of CD28 expression after 15 days culture with IL-15. 
Fluorescence-activated cell sorting-sorted naïve CD8+CD45RO−CCR7+CD28+ 
T cells were stained with proliferation dye to study CD28 expression after 
proliferation upon IL-15 stimulation (50 ng/ml). Proliferation of the naïve CD8 
T cells was assessed after 15 days of culture. (a) Gate setting for the 
identification of the population doublings (PDs). Within the different PDs,  
(B,e) expression of CD28 per generation, (c) CD28 expression per cell  
per generation, (D,F) CD45RO, and (F) CCR7 expression was assessed. 
MFI = median fluorescence intensity. Significance (*p < 0.05, **p < 0.01)  
is depicted. N = 3.
FigUre s3 | Loss of CD28 expression after 5 and 10 days culture with IL-15. 
Fluorescence-activated cell sorting-sorted naïve CD8+CD45RO−CCR7+ 
CD28+ T cells were stained with proliferation dye to study CD28 expression  
after proliferation upon IL-15 stimulation (50 ng/ml). Proliferation of the naïve  
CD8 T cells was assessed after (a–F) 5 and (g–l) 10 days of culture.  
(a,g) Gate setting for the identification of the population doublings (PDs). Within 
the different PDs (B,e,h,K) expression of CD28 per generation, (c,i) CD28 
expression per cell per generation, (D,F,J,l) CD45RO and (F,l) CCR7 
expression was assessed. MFI = median fluorescence intensity. Significance 
(*p < 0.05, **p < 0.01) is depicted. N = 3.
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